Freedom Business Summit 2024: A Global Gathering For Entrepreneurs, Freedom Seekers, and Global Citizens ACN Newswire

Freedom Business Summit 2024: A Global Gathering For Entrepreneurs, Freedom Seekers, and Global Citizens

Estonia, Sept 24, 2024 - (ACN Newswire via SeaPRwire.com) - The Freedom Business Summit 2024 returns for another powerful edition, bringing together global citizens, entrepreneurs, and freedom seekers to explore strategies for global mobility, offshore structures, and the creation of location-independent lifestyles.Organized in official partnership with e-Residency Estonia, Incorp Indonesia, and EC Holdings Singapore, this two-day virtual summit will offer cutting-edge insights from the world’s leading experts on these emerging topics.This year’s summit aims to address key questions for those seeking personal and financial sovereignty. Over 4,000 attendees from 80 countries and 100 industries are expected to participate in live keynotes, expert-led panel discussions, and focused workshops.Topics range from relocation strategies and second citizenship to investment migration, Bali real estate opportunities, and the benefits of Estonia e-Residency for global entrepreneurs.Some of the featured speakers include:Sergei Zunajev from e-Residency Estonia, offering insights on the future of digital entrepreneurship.Max Chernov, revealing secrets to growing and building a successful YouTube channel.Show Nemoto, a mindset coach, guiding attendees on how to reprogram their minds to achieve business success.Pandu Bisramadani from Incorp Indonesia, presenting opportunities for investment and market entry strategies in Southeast Asia.Philippe A. May, founder of EC Holdings, discussing the strategic value of offshore investments.Joseph Shine, Ambassador of Palau Digital Residency, highlighting the benefits and process of obtaining Palau Residency ID.The event will focus on two main themes:- Day 1: Global Mobility, Investments, and Building Virtual Companies- Day 2: Offshore Strategies and Personal SovereigntyDenis Dovgal, the founder of Freedom Business Summit, emphasizes the importance of self-reliance in an increasingly unpredictable world:“Global mobility and personal sovereignty are no longer just dreams – they’re necessities for anyone who wants to thrive in today’s uncertain world. The strategies shared at Freedom Business Summit will empower you to navigate life on your terms.”Attendees will have access to exclusive knowledge on securing residency in emerging LATAM destinations such as Paraguay, leveraging the Flags Theory to maximize sovereignty, and creating global mobility strategies without reliance on expensive legal firms.Freedom Business Summit 2024 is the ultimate event for those committed to designing a life of freedom, on their own terms.About Freedom Business SummitThe Freedom Business Summit is an annual event that connects global citizens, entrepreneurs, and freedom seekers from across the world.The summit focuses on strategies for personal sovereignty, global mobility, offshore investments, and building location-independent businesses.The event brings together leading voices to educate, inspire, and provide actionable insights for those aiming to reclaim their freedom. For more information, visit www.freedomsummit.net.Media Contact:For all media inquiries, interviews, or sponsorship information, please contact: media@fsummit.net Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Mazda to open new R&D office in Azabudai Hills in early summer 2025 JCN Newswire

Mazda to open new R&D office in Azabudai Hills in early summer 2025

TOKYO, Sept 24, 2024 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation will open a new R&D office in the cosmopolitan Azabudai Hills (Azabudai, Minato-ku, Tokyo) in early summer 2025, an area projected to see continuous development.Mazda has set out its 2030 VISION "to be a car-loving company that creates moving experiences through the 'joy of driving'" and aspires to an ideal where everyone connected to the Mazda brand feels mentally refreshed, physically invigorated, and optimistic about each day.As advanced technologies such as generative AI gain widespread use, it is crucial to continue innovating software technologies alongside traditional hardware to deliver vibrant, engaging experiences to our customers through their cars. The new R&D office is expected to house development facilities, particularly in software, demonstrating Mazda's goal to become a dynamic workplace of choice for software engineers. It will also function as a hub for collaborative innovation, fostering partnerships with universities, companies, and research institutions in the Tokyo metropolitan area.Based on the belief that our people are our most valuable resource, Mazda is promoting initiatives, like this new R&D office, to maximize the contributions of its personnel, including corporate culture reforms, improvements to HR systems, and the establishment of value-creation platforms.In our aspiration to create a comfortable working environment, the new R&D office will feature an open workspace and be equipped with the latest technology. Further details regarding the specific floor area and facilities will be announced in due course.Azabudai Hills, the location for Mazda's new R&D officeTrue to Mazda's "human-centered" philosophy and commitment to the pursuit of a comfortable and rewarding work environment, we endeavor to create an exemplary company where every employee feels the pride and energy to work with enthusiasm. Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis JCN Newswire

Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis

Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” (mecobalamin) in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. In May 2022, it received orphan drug designation, and a new drug application was submitted in January 2024, leading to this approval.This approval is based on the results of JETALS (The Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS), multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial in 130 patients with ALS, that was conducted as an investigator-initiated trial by a research team with Extraordinary Professor Ryuji Kaji (Principal Investigator), Tokushima University, and Professor Yuishin Izumi (Coordinating Investigator), the Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, and Professor Satoshi Kuwabara (Coordinating Investigator), the Department of Neurology, Chiba University Graduate School of Medicine.In JETALS, the mecobalamin 50mg group showed a statistically significant slowing of progression compared to the placebo group in the change in total score from the end of the observation period to week 16 of the treatment period in the primary endpoint, the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) (slowing decline by approximately 43%, p=0.01).1 The adverse drug reaction incidence rates were 1.6% in the placebo group and 7.7% in the mecobalamin 50 mg group. Adverse reactions observed in the mecobalamin 50 mg group included constipation, injection site pain, fever, electrocardiogram QT prolongation and rash, each occurring in 1.5% of patients.2ALS is an intractable, progressive, neurodegenerative disease that results in severe muscle atrophy and weakness in the muscles due to motor neuron dysfunction. As the main cause of death is respiratory failure due to paralysis of the respiratory muscles, without the use of an artificial respirator, death occurs within approximately 2 to 5 years from the onset of the disease.3 The number of patients in Japan is estimated to be approximately 10,000. 3 Currently, there is no curative treatment established for ALS, and since there are only limited number of medicines approved in Japan and abroad, this is a disease with significant unmet medical needs.Eisai considers neurology a therapeutic area of focus. As a human healthcare company, Eisai is committed to further addressing the diverse needs of, and increasing the benefits of, patients and their families by providing Rozebalamin as a new treatment option for ALS patients.1. Product Outline1) Product nameRozebalamin® for Injection 25 mg2) Generic nameMecobalamin3) Indication for useSlowing progression of functional impairment in amyotrophic lateral sclerosis4) Dosage and administrationThe usual dose of mecobalamin in adults is 50 mg a day, twice a week, injected intramuscularly.About Rozebalamin (generic name: mecobalamin, development code: E0302)Mecobalamin is approved and marketed as Methycobal®, a 500 µg injection of mecobalamin indicated for the treatment of peripheral neuropathies and megaloblastic anemia caused by vitamin B12 deficiency. Methycobal is also approved as a tablet formulation (250 µg and 500 µg) as well as a fine granule formulation (0.1%) indicated for the treatment of peripheral neuropathies. While the mechanism of action of mecobalamin against amyotrophic lateral sclerosis (ALS) is not known, it has been suggested in non-clinical research that mecobalamin may have efficacy through a neuroprotective effect and regeneration of nerve axons. Since the 1990s, clinical research has been carried out on ultrahigh-dose mecobalamin in ALS by a study group on neurodegenerative disease, funded through the Ministry of Health, Labour and Welfare's Specified Disease Treatment Research Program. Short- and long-term trials of intramuscular injection of mecobalamin at 25 mg and 50 mg per day, which is respectively 50 and 100 times the approved dosage of Methycobal, suggested that ultrahigh-dose mecobalamin could have a clinical effect in ALS, and Eisai then conducted the Phase II/III clinical trial (Study 761) from 2006. Eisai submitted a new drug application for ultrahigh-dose mecobalamin as treatment for ALS in May 2015 but withdrew the application in March 2016 after the Pharmaceuticals and Medical Devices Agency (PMDA) indicated that additional clinical trials were necessary.After obtaining favorable results in the investigator-initiated Phase III trial JETALS, and following consultation with Tokushima University, Eisai submitted a new drug application for the treatment of ALS in Japan in January 2024, leading to this approval.About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS)The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS).1Mecobalamin 50 mg or placebo was administered intramuscularly twice weekly for 16 weeks to 130 ALS patients who had suffered from ALS for less than one year, were classified as “definite”, “probable”, or “probable- laboratory supported” according to the Updated Awaji Criteria, had an ALS severity rating of grade 1 or 2, had a decrease of 1 or 2 points in the total score on the Revised ALS Functional Rating Scale-Revised (ALSFRS-R) 12 weeks prior to administration, and had a forced vital capacity (%FVC) of more than 60%.2The primary endpoint was the change in ALSFRS-R total score from the end of the observation period to week 16 of the treatment period. The change was -2.7 [95% confidence interval (CI): -3.9, -1.5] in the mecobalamin50 mg group and -4.6 [95% CI: -5.8, -3.4] in the placebo group, with a difference in change of 2.0 (95% CI: 0.4, 3.5; p=0.012), verifying the superiority of mecobalamin 50 mg over placebo.2 The adverse drug reaction incidence rate was 1.6% (1/64 cases) in the placebo group and 7.7% (5/65 cases) in the mecobalamin 50 mg group. Adverse drug reactions observed in the mecobalamin 50 mg group were constipation, injection site pain, fever, electrocardiogram QT prolongation, and rash, occurring in 1.5% (1/65 cases) each.2(1) Oki R, et al. Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis a randomized clinical trial. JAMA Neurol. 2022;79(6):575-583.(2) Information stated in the package insert.(3) Japan Intractable Diseases Information Center, Amyotrophic lateral sclerosis (ALS), Designated intractable disease (2). https://www.nanbyou.or.jp/entry/52. Last accessed: September 2024. (Japanese only)Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Valuufy CEO to present at the UN Science Summit (SSUNGA79) JCN Newswire

Valuufy CEO to present at the UN Science Summit (SSUNGA79)

KYOTO, Japan, September 24, 2024 - (JCN Newswire via SeaPRwire.com) - Valuufy, a pioneering force in sustainability assessment, announces its CEO Kyle Barnes will present at the prestigious Science Summit at the United Nations General Assembly (SSUNGA79) on September 26 as part of a larger panel session on the important role of SMEs in global sustainability efforts. This marks the third consecutive year that the Value Model has been included in this global forum.Valuufy's presentation will showcase how SMEs can become a more powerful force in global sustainability efforts. The session, "Empowering SMEs: Blockchain & AI for Sustainable Stakeholder Value", will also demonstrate how the ValuuCompass enables businesses of all sizes to measure, understand, and enhance value creation across all stakeholder groups.This is the third time the Value Model (which evolved into the ValuuCompass) has been presented at the SSUNGA, reinforcing the global relevance and potential of the ValuuCompass in addressing complex sustainability challenges, and offering a potential outline for how a post-SDGs could function."The ValuuCompass aims to become a global standard for sustainability by 2030, and this platform allows us to get important feedback at one of the world’s most important sustainability-focused events. We're excited to explore how blockchain and AI can help smaller businesses navigate the complex world of sustainability and position themselves as leaders in the post-SDG era," shares Kyle Barnes, CEO of Valuufy."We are honored to introduce the ValuuCompass as a powerful tool for driving sustainable business practices, especially for SMEs at this year’s Science Summit for the United Nations General Assembly."The ValuuCompass was developed by the Value Research Center at Doshisha University and is a practical tool that helps organizations measure their impact on seven key stakeholders: the organization itself, shareholders, employees, customers, partners, society, and the planet.“We know that a post-SDG world needs to act for people, planet, and prosperity and Valuufy speaks to this imperative. Its participation in SSUNGA79 builds on the discussions from previous years' presentations, which introduced the Value Model and explored its role in creating a sustainable post-SDG future,” acknowledges Heather Young, SSUNGA Japan Co-Chair.This year's focus on empowering SMEs with blockchain and AI technologies demonstrates Valuufy's commitment to making sustainable practices accessible and impactful for businesses of all sizes, and will include speakers across academia and business to explore how best to integrate the collective actions of SMEs to ensure global sustainability success.The virtual session is scheduled for Thursday, September 26, 2024, from 16:00 to 18:00 JST. There is no cost to attend, but registration is required: https://sched.co/1l8mcAbout ValuufyValuufy seeks to transform how the world understands and acts on sustainability. Founded in 2024, Valuufy, Inc is a registered Japanese startup in Kyoto, Japan, born of 10 years’ academic value research at Doshisha University and the Value Research Center. Led by an international team with expertise in value research, sustainability strategies, innovative technologies, business development, and ESG assessments, Valuufy provides a suite of products and services to promote value creation activities across stakeholders for businesses of all sizes. Valuufy aims to set new standards in transparent, data-driven decision-making in the realm of sustainability and value creation. For more on Valuufy's products and services and its impact on shaping the future of sustainability strategies, visit www.valuufy.com.Press and Media enquiries:news@valuufy.comFollow us:linkedin.com/company/valuufy Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Anticancer Agent “Tasfygo(R) Tablets 35mg” (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or Rearrangements JCN Newswire

Anticancer Agent “Tasfygo(R) Tablets 35mg” (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or Rearrangements

TOKYO, Sept 24, 2024 - (JCN Newswire via SeaPRwire.com) - Anticancer Agent “Tasfygo(R) Tablets 35mg” (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or RearrangementsEisai Co., Ltd. announced today that it has obtained manufacturing and marketing approval for fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor “TASFYGO® Tablets 35mg” (tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy. In Japan, it has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW), and the marketing authorization application was submitted in December 2023.This approval is based on data such as the results of a multicenter, open-label, single-arm clinical phase II trial (Study 201) conducted by Eisai in Japan and China. Study 201 enrolled 63 patients with unresectable advanced or metastatic cholangiocarcinoma with FGFR2 gene fusions or rearrangements previously treated with gemcitabine-based combination chemotherapy. The primary endpoint of this study was objective response rate (ORR), and secondary endpoints included safety.1 This study achieved its primary endpoint and exceeded a prespecified tumor response threshold (15%) with statistical significance: ORR of patients treated with TASFYGO was 30.2% (90% confidence interval (CI): 20.7-41.0) as assessed by independent imaging review. Treatment-emergent adverse events (incidence of 25% or more) observed in this study were hyperphosphataemia (81.0%), palmar-plantar erythrodysaesthesia syndrome (44.4%), diarrhoea (36.5%), aspartate aminotransferase increase (31.7%), alanine aminotransferase increase (28.6%) and stomatitis (25.4%).The estimated number of patients in Japan with biliary tract cancer is approximately 22,0002,3 with approximately 25% of the five-year relative survival rate,2 making it an intractable cancer with the second worst prognosis following pancreatic cancer. Since drug therapy options are limited in comparison with other cancers, it is a disease with significant unmet medical needs. FGFR2 gene fusions or rearrangements are observed in approximately 14% of intrahepatic cholangiocarcinoma, which accounts for 15-30% of biliary tract cancers.4 FGFR genetic aberrations such as the gene fusions are known to be deeply involved in the proliferation, survival and migration of cancer cells as well as tumor angiogenesis and drug resistance. As these genetic aberrations in FGFRs have been observed in various other types of cancers as well as biliary tract cancer, there is growing interest in FGFRs as a promising target for cancer therapy. TASFYGO is thought to show tumor growth inhibition by selectively inhibiting FGFR1, 2 and 3, and blocking those signals.5,6 In non-clinical studies, the antitumor activity of TASFYGO was confirmed in cells expressing the FGFR2-fusion genes, which were identified by the National Cancer Center Japan (Headquarters: Tokyo) through large-scale genomic analysis of Japanese biliary tract cancer. The companion diagnostic test to detect FGFR2 gene fusions or rearrangements for the use of TASFYGO in biliary tract cancer, “AmoyDx® FGFR2 Break-apart FISH Probe Kit” by Nihon Stery, Inc. (Headquarters: Tokyo) was approved in August 2024.7Eisai aims to make continuous efforts to meet the diversified needs of and increase the benefits provided to patients with cancer, their families, and healthcare professionals, by delivering TASFYGO as a new treatment option for biliary tract cancer with FGFR2 gene fusions or rearrangements.1. Product Information1) Brand nameTASFYGO® Tablets 35mg2) Generic nameTasurgratinib succinate3) IndicationsUnresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy4) Dosage and AdministrationThe usual adult dose of tasurgratinib is 140mg orally once daily under fasting conditions. The dose may be reduced appropriately according to the condition of the patient.About “TASFYGO® Tablets 35mg” (tasurgratinib succinate, Development Code: E7090) Discovered in-house by Eisai’s Tsukuba Research Laboratories, TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against fibroblast growth factor receptors (FGFR) FGFR1, FGFR2 and FGFR3. Distinct from prior known FGFR inhibitors, TASFYGO has a basic structure which lacks the dimethoxyphenyl moiety, and in a kinetic interaction analysis study, it was observed that TASFYGO demonstrates antitumor activities due to inhibition of kinase activity with a binding mode (Type V) that exhibits rapid and potent binding as well as high selectivity to FGFR. 5,6In non-clinical studies for biliary tract cancer, NIH/3T3 cells expressing FGFR2-AHCYL1, FGFR2-KCTD1, FGFR2-BICC1 or FGFR2-TXLNA as FGFR2-fusion genes, provided by the National Cancer Center Japan, were used. The antitumor activity of TASFYGO against FGFR2 gene fusion-positive cancers was confirmed in these models by evaluating its effect on anchorage-independent growth and subcutaneously transplanted tumor growth in mice.6A Phase I clinical trial is underway in Japan in patients with estrogen receptor-positive and HER2-negative breast cancer.(1) Furuse J. et al. Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA). 2024 ASCO Gastrointestinal Cancers Symposium; Abstract No. 471. https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.3_suppl.471(2) Latest statistics, Cancer Information Service, National Cancer Center, Japan. (Japanese only)(3) The 23rd Follow-up Survey Reports for Primary Liver Cancer Cases in Japan (2014-2015), 2023. (Japanese only)(4) Arai Y. et al., Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma, Hepatology, 2014, 59, 1427-1434.(5) Miyano SW. et al., E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models, Molecular Cancer Therapeutics, 2016, 15, 2630-2639.(6) Kawano S. et al., Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion, Anticancer Research, 2024, 44, 2393-2406.(7) AmoyDx® FGFR2 Break-apart FISH Probe Kit Approved as Companion Diagnostic for Eisai’s Tasurgratinib in Japan. Available at: https://www.amoydiagnostics.com/about/press-releases/245 Last accessed: September 2024.Media Inquiries:Public Relations DepartmentEisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Autobrains推出Air2Road:自動駕駛的尖端定位技術 ACN Newswire

Autobrains推出Air2Road:自動駕駛的尖端定位技術

德國慕尼黑和以色列特拉維夫, 2024年9月24日 - (亞太商訊 via SeaPRwire.com) - Autobrains, 全球領先的人工智慧汽車解決方案提供商,欣然推出其最新創新:Air2Road,這是一項突破性的定位技術,旨在增強先進駕駛輔助系統(ADAS)和自動駕駛解決方案的能力。基於Autobrains的液態人工智慧技術,Air2Road提供精準的即時車輛定位,確保安全高效的導航,甚至在遮擋、惡劣天氣和複雜城市環境等挑戰性條件下也能表現出色。Autobrains的Air2Road定位技術 將空中圖像與地面圖像融合,實現高精度和可靠的定位。隨著汽車行業加速向完全自動駕駛汽車邁進,可靠和準確的定位對於確定車輛位置和駕駛環境至關重要。傳統定位系統主要依賴全球導航衛星系統(GNSS)或眾包地圖,面臨覆蓋範圍有限、成本高和易受干擾等重大挑戰。此外,這些系統依賴單一來源的傳感器信息,導致頻繁出現錯誤,並在駕駛過程中過度依賴一種輸入類型。“Air2Road是自動駕駛技術的變革者,”Autobrains的首席執行官兼創始人Igal Raichelgauz表示。“通過提供多模態冗餘和無與倫比的精度,Air2Road推動了車輛導航和安全領域的極限,確保自主系統在最具挑戰性的條件下也能可靠運行。”Air2Road通過結合來自兩種獨立模式(空中圖像和地面感知)的特徵,設定了車輛定位的新標準,確保了多模態冗餘和準確性。這些特徵是對駕駛環境及其中物體的稀疏二進制高維表示。這種創新的方法克服了傳統系統固有的許多限制,包括:多模態冗餘:通過創建來自兩種獨立模式(空中圖像和地面數據)的特徵的聯合表示,Air2Road實現了前所未有的多模態冗餘優勢。其他現有系統通常依賴於一車隊使用相似的地面數據源,這增加了重複錯誤的可能性,並使其過度依賴單一信息來源。全面覆蓋:與基於GNSS的系統不同,Air2Road憑藉其基於特徵的技術,即使在樹木、橋樑、建築物之間或任何GNSS信號接收不良的情況下,仍能有效運作。空中感知:空中圖像生成額外的數據層,例如道路標線、交通標誌和障礙物,從而支持更安全和更高效的駕駛決策,並為即時感知提供冗餘。可擴展和高效:傳統定位系統(如眾包地圖)需要一車隊車輛反覆行駛在道路上收集數據並構建地圖,才能為任何車輛提供定位服務。而Air2Road使得首輛上路的車輛能即時實現精準定位,確保在各個地區可擴展部署且不妥協於準確性。成本效益:Air2Road兼容來自多個供應商的經濟實惠的空中圖像,其壓縮的特徵技術使得大面積數據能夠直接存儲在車輛上。這使得系統具備低記憶體和低頻寬的優勢,消除了對持續雲連接的需求。環境感知路徑規劃:通過利用道路狀況、交通流量和停車區域的即時數據,Air2Road支持更安全、更優化的導航。受到人腦處理多感官信息能力的啟發,Air2Road複製了情境意識和注意力集中等機制,以確保準確的決策。通過過濾無關數據並關注關鍵元素,如道路邊緣和建築物,該系統顯著提高了定位精度。憑藉其數據驅動的方法和革命性的雙模態技術,Air2Road將重新定義定位的未來,促進更安全、更可靠的自動駕駛解決方案。有關Autobrains及其尖端液態人工智慧和ADAS解決方案的更多信息,請訪問 autobrains.ai。聯繫信息Sophia EichlerDirector of Marketingmedia@autobrains.ai+49 15167066494來源: Autobrains Copyright 2024 亞太商訊 via SeaPRwire.com.
More
ISDNP Enters Strategic Partnership with Vietnam’s Red River Group through MOU SeaPRwire

ISDNP Enters Strategic Partnership with Vietnam’s Red River Group through MOU

Seoul, Korea – September 24, 2024 – (SeaPRwire) – ISDNP (https://isdnp.co.kr/), in partnership with JournalInNews, has taken a significant step towards entering the Vietnamese market by forging an alliance with a prominent local enterprise. On the 19th, the two companies jointly announced, the signing of a Memorandum of Understanding (MOU) on the 17th with Vietnam’s Red River Group to formalize their strategic collaboration. This agreement follows a high-level meeting on the 16th at Red River’s headquarters in Hanoi, Vietnam, between Insoo Park, the Chairman of JournalInNews, and LE CONG HOANG, Chairman of the Red River Group, during which both parties discussed the framework for a strategic partnership. The MOU outlines key areas of cooperation, including the introduction of ISDNP’s pedestrian signal voice guidance system in Vietnam and the promotion of JournalInNews’s JsetCoin within the Vietnamese business landscape. Both companies are poised to jointly deploy ISDNP’s pedestrian signal system nationwide, leveraging Red River Group’s extensive network and resources. Red River Group is a prominent, diversified conglomerate in Vietnam, with business interests spanning petroleum distribution, tourist vehicle rentals, smart parking solutions, automotive management centers, and emergency response infrastructure. Notably, its traffic rescue centers, which provide critical emergency assistance, are recognized as essential contributors to Vietnam’s transport and safety sectors. Through this partnership, both parties anticipate enhancing bilateral economic, social, and cultural exchanges while delivering substantive outcomes. ISDNP has committed to supplying the requisite technical expertise and information necessary for the successful deployment of the pedestrian signal voice guidance system, while Red River Group has pledged comprehensive support to ensure the project’s smooth execution. Additionally, JournalInNews has designated Red River Group as its strategic partner to facilitate the expansion of JsetCoin within the Vietnamese market. Both parties are exploring various collaborative avenues, including the potential establishment of a local subsidiary, aimed at fostering a synergistic partnership and ensuring the efficient exchange of essential information. This MOU is expected to strengthen economic ties between the two countries and serve as a catalyst for sustained growth. Both parties have committed to maintaining close cooperation to ensure the successful realization of the agreement’s objectives. Media contact Brand: ISDNP Contact: Media team Email: support@isdnp.co.kr Website: https://isdnp.co.kr/ SOURCE: ISDNP The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...
More
The Clean Cities And Urban Development Forum 2024 – Driving Innovation For Sustainable Waste Management & Urban Development ACN Newswire

The Clean Cities And Urban Development Forum 2024 – Driving Innovation For Sustainable Waste Management & Urban Development

KUALA LUMPUR, Sept 24, 2024 - (ACN Newswire via SeaPRwire.com) - The Clean Cities and Urban Development Forum 2024 is set to take place on November 20 - 21, 2024, at the prestigious M Resort Hotel, Kuala Lumpur. This exclusive event promises to bring together global leaders, industry experts, policymakers, and innovators, all united by a shared vision of creating cleaner, greener, and more sustainable cities.More than just a conference, the Clean Cities and Urban Development Forum 2024 is a call to action. In an era marked by rapid urbanization and environmental challenges, it’s essential for cities and communities to adopt smarter and more sustainable approaches to waste management and urban development. As the world’s urban population grows, cities are facing increasing pressure to address waste generation, resource consumption, and environmental degradation. From air pollution to overflowing landfills, the challenges are clear. However, this forum will provide a unique opportunity to explore the solutions that can transform urban areas into sustainable, eco-friendly environments for future generations.Event Highlights:The Clean Cities and Urban Development Forum 2024 will focus on innovative strategies that aim to reduce waste, promote recycling, and minimize environmental impacts. This year’s theme revolves around the integration of smart technologies and zero-waste initiatives to foster urban growth through safe and effective practices.Key topics to be covered include:- Smart Technologies for Waste Management: Industry leaders will present groundbreaking solutions to optimize waste management through smart technologies such as IoT (Internet of Things), AI-powered waste segregation systems, and real-time data analytics for efficient collection and disposal. These solutions promise to revolutionize how cities manage waste while reducing costs and improving environmental outcomes.- Advanced Strategies for Waste Segregation and Recycling: Attendees will explore cutting-edge techniques for effective waste segregation and recycling that aim to significantly reduce the amount of waste sent to landfills. Best practices from cities leading the charge in sustainable waste practices will be highlighted, providing actionable insights for attendees to implement in their own municipalities.- Waste-to-Energy Innovations: One of the most exciting discussions will focus on the pioneering innovations in waste-to-energy and biogas production. Experts will demonstrate how organic waste can be converted into valuable resources such as electricity, biofuels, and compost. These technologies offer a promising pathway for cities to turn their waste problems into sustainable energy solutions.- CO2 Reduction and the Valorisation of Solid Waste: The forum will delve into advanced CO2 reduction strategies, including the valorisation of solid waste into biofuels, compost, and recyclable materials. These techniques not only mitigate greenhouse gas emissions but also create economic opportunities through the circular economy, driving sustainability forward.- Collaborative Urban Development: Attendees will also have the chance to hear from policymakers and urban planners about successful urban development strategies that prioritize sustainable growth. By integrating green spaces, energy-efficient infrastructure, and sustainable building practices, cities can reduce their carbon footprint while enhancing the quality of life for residents.Why AttendThe Clean Cities and Urban Development Forum 2024 is a must-attend event for anyone involved in the fields of urban development, environmental sustainability, waste management, and renewable energy. It is designed for those who want to stay at the forefront of sustainability innovations and urban growth strategies that align with the United Nations’ Sustainable Development Goals (SDGs).By attending, participants will not only witness groundbreaking discussions but also become part of the change driving sustainable urban growth across Asia and beyond. This is an unparalleled opportunity for stakeholders in the public and private sectors, as well as those involved in urban planning, environmental management, and technology development, to come together and shape the future of urban sustainability.Here’s what makes this forum unique:1. Access to Industry Experts: The forum will feature speakers from multi-diversified industries across Asia and beyond, providing participants with direct access to some of the brightest minds in sustainability and urban planning.2. Networking Opportunities: With a diverse group of attendees including industry leaders, policymakers, and sustainability experts, participants will have numerous opportunities to connect, collaborate, and share ideas with peers from around the world.3. Actionable Insights: Each session is designed to provide tangible takeaways that attendees can implement in their own projects or businesses. From learning how to integrate smart waste management solutions to exploring the latest advancements in waste-to-energy, this forum offers tools and strategies for real-world application.4. Future-Focused Discussions: The forum will not only address today’s challenges but will also explore emerging trends and technologies that will shape the future of sustainable urban development. From biogas production to next-generation recycling technologies, attendees will leave with a clear understanding of where the industry is headed.Keynote SpeakersThe event will showcase an esteemed lineup of speakers who are pioneers in their respective fields, offering valuable insights and strategies for sustainable development. Speakers include:- Anwar Syahrin Abdul Ajib, Managing Director & Group Chief Executive Officer at Malakoff. With extensive experience in leading sustainable energy initiatives, Anwar will discuss the role of energy in urban development and how clean energy can drive sustainable cities.- Dr. Maria Neira, Director of the Department of Environment, Climate Change, and Health at the World Health Organization. Dr. Neira will focus on the intersection of public health and sustainable waste management, emphasizing the need for cities to adopt eco-friendly waste practices to protect human health.- Tengku Erina Tengku Nasrudin, Chief Executive Officer at AECA SOLUTIONS. As a leader in environmental solutions, Tengku Erina will present on innovative strategies for waste-to-energy transformation and how cities can harness waste as a resource.- Vinod Sekhar, Chairman & Group CEO at Petra Group. Vinod will share his insights on the circular economy and how businesses can lead the way in creating sustainable, waste-free communities through innovative technologies.- Dr. Margaret Kuyor, Deputy Secretary (Circular Economy Policy) at the Urban Sustainability & Green Environment Division, Ministry of Housing & Local Government. Dr. Kuyor will discuss Malaysia’s ongoing initiatives in circular economy and urban sustainability, with a focus on policy frameworks that can foster greener cities.SessionsThe Clean Cities and Urban Development Forum 2024 will present a wide range of sessions focused on innovative waste management strategies. Topics include biological waste treatments, waste-to-energy technologies, AI-powered sludge and wastewater management, and reducing carbon and water footprints. The forum will also explore biofuel production, advanced recycling techniques, e-waste recovery, hydrogen production, and the role of municipalities in sustainability.ConclusionThe Clean Cities and Urban Development Forum 2024 is more than just an event—it’s a global platform for action. Join us to learn from the best minds in the industry, share your own experiences, and play a pivotal role in creating a cleaner, greener, and more sustainable future for urban environments across the world.About The Clean Cities and Urban Development Forum 2024The Clean Cities and Urban Development Forum 2024 is organized by CT Event Asia, a leading provider of high-level events in the field of environmental sustainability and urban development. With a focus on knowledge-sharing and fostering innovation, CT Event Asia brings together experts from diverse industries to address the most pressing challenges of our time.For more information, please contact:Amina KanteSenior Marketing ManagerCT Event AsiaPhone: +601161888699Email: amina@ctasia.com.myWebsite: https://www.cleancitiesforum.com/Registration: Early bird discounts are available until October 15th, 2024. Register at: https://www.cleancitiesforum.com/request Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Anson Receives US$330M Letter of Interest from Export-Import Bank of the United States ACN Newswire

Anson Receives US$330M Letter of Interest from Export-Import Bank of the United States

Highlights:A non-binding Letter of Interest received from the US EXIM Bank for up to US$330M in long term debt financing for the construction of a lithium production plant at the Paradox Basin in Utah, USA.US EXIM is the official export credit agency of the US Federal Government, whose objectives include strengthening America’s Supply Chains through it’s “Make More in America” Initiative.Anson continues to advance development of its globally significant lithium projects located in the Paradox Basin, Utah.NEWPORT BEACH, CA, Sept 24, 2024 - (ACN Newswire via SeaPRwire.com) - Anson Resources Limited (ASX:ASN) ("Anson Resources" or "the Company") is pleased to announce that its 100% owned US subsidiary, A1 Lithium, has received a non-binding and conditional Letter of Interest (LoI) from the Export-Import Bank of the United States (US EXIM) to provide a debt funding package of up to US$330 million (A$500 million1) for the construction of a lithium production plant in Utah, USA, under the "Make More in America" Initiative.The LoI from US EXIM represents a material step in Anson's project funding strategy and is recognition of the strong engagement the Company has had with the US Government and with industry partners in the United States.Anson's Executive Chairman and CEO Bruce Richardson commented:"We are delighted to receive this Letter of Interest from US EXIM following extensive collaboration with multiple government and industry stakeholders in the United States. This LoI reflects our continued strong development, permitting progress and community engagement efforts in the United States and Southern Utah in particular.The United States seeks to develop a domestic and reliable source of critical minerals and the Paradox Basin, which we believe is the largest source of lithium in the United States, has a significant role to play. Our DLE technology will produce one of the most environmentally friendly sources of lithium globally. This will support the development of the new energy economy, from electric vehicles to drones and defense."Anson's Chief Financial Officer Matthew Beattie commented:"This LoI reflects the Paradox Project in Sothern Utah's potential to be a major source of new, high paying jobs and stimulate investment in the region. While non-binding, the Company views the LoI as an important step in advancing our project financing plan for the development of our world class Paradox Basin projects. If finalised, the US EXIM facility will make up a substantial portion of the overall funding requirements."The LoI from EXIM does not represent a financing commitment and is a preliminary step in the formal EXIM application process. The debt financing is subject to the satisfactory completion of due diligence, the negotiation and settlement of final terms, and the negotiation of definitive documentation. There can be no assurance that the debt financing will be completed on the terms as described above or at all. The Company will update the market upon reaching a definitive agreement with US EXIM for funding support.About the Export-Import Bank of the United StatesUS EXIM is the official export credit agency of the United States of America. EXIM is an independent Executive Branch agency with a mission of supporting American jobs by facilitating the export of U.S. goods and services.As published in its 2023 Annual Report, EXIM has current exposure to US$1,476.7 billion in lending across 148 countries around the world. The default rate across the portfolio is 0.98%, reflecting the high standards of credit required to obtain EXIM financing. Furthermore, EXIM's charter requires that it supplement and encourage, not displace, private capital.For further information please contact:Will MazeHead of Investor RelationsE: investors@ansonresources.comPh: +61 7 3132 7990www.ansonresources.comFollow us on Twitter @anson_irSOURCE: Anson Resources Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Experian Launches Global Ultimate Beneficial Ownership Compliance Solution for Enhanced KYC/KYB Verification ACN Newswire

Experian Launches Global Ultimate Beneficial Ownership Compliance Solution for Enhanced KYC/KYB Verification

SINGAPORE, Sept 24, 2024 - (ACN Newswire via SeaPRwire.com) - Experian Singapore (Experian) recently introduced Global UBO (Ultimate Beneficial Ownership), a comprehensive report to the market, designed to revolutionise due diligence and compliance processes in onboarding, portfolio management, and customer lifecycle management.This innovative resource provides detailed insights and evaluations of cross-border UBOs in over 200 markets, helping small and medium enterprises (SMEs), corporations and financial institutions navigate the complexities of regulatory compliance and risk management.In an increasingly globalised and regulated marketplace, the importance of thoroughly understanding the complexities of business structures cannot be overstated. Experian’s Global UBO reports offer a standardised, detailed analysis of UBOs in one comprehensive report. These reports equip organisations with the critical information needed to make well-informed decisions, ensuring they meet the highest standards of due diligence, compliance, Know Your Customer (KYC) and Know Your Business (KYB) needs.It’s no longer only financial institutions who have to comply with UBO regulations. Regulators are bringing their rules in line with global efforts to promote beneficial ownership transparency across other sectors – namely legal, real estate, corporate service providers and accountancy.In Singapore, real estate developers with more than four units have to comply with the anti-money laundering and terrorism financing provisions. (ref https://www.ura.gov.sg/Corporate/Guidelines/Developers/Anti-Money-Laundering)“Experian Global UBO helps businesses know exactly who they are doing business with, ensuring that their business partners comply with national and international laws on money laundering (AML), bribery and corruption, and regulations related to KYC/KYB. It automates and enhances the due diligence process by providing a reliable and comprehensive UBO report,” said Kabir Khanna, General Manager, Experian Credit Services Singapore.Key benefits of the Global UBO report includes:Enhanced Due Diligence: Comprehensive evaluations help identify potential risks and ensure thorough vetting of UBOs during the onboarding process.Streamlined Portfolio Management: Leads to more effective and efficient risk management and decision-making, fostering a more secure and stable portfolio.Improved Customer Lifecycle Management: Insights ensure that organisations remain compliant with evolving regulations and maintain high standards of customer relationship management.These reports are an essential tool for financial institutions, regulatory bodies, and businesses committed to maintaining compliance and managing risk in today's complex environment. By leveraging Experian’s Global UBO reports, organisations can confidently navigate the challenges of regulatory compliance, mitigate risks, and enhance their overall operational integrity.In conjunction with the launch of Global UBO reports in Southeast Asia, Experian is also introducing a global monitoring service for Credit Reports. These are refreshed investigative credit reports produced over a predetermined period to help monitor critical business relationships in a proactive manner.For more information about Experian’s Global UBO solution and the new Global Monitoring Service for Credit Reports, please visit www.experian.com.sg.For media enquiries: PRecious Communications for Experianexperian@preciouscomms.com About ExperianExperian is a global data and technology company, powering opportunities for people and businesses around the world. We help redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics, and software. We also assist millions of people to realise their financial goals and help them to save time and money. We operate across a range of markets, from financial services to healthcare, automotive, agribusiness, insurance, and many more industry segments. We invested in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

量化對沖基金管理公司ActusRayPartners 榮獲 HFM 亞太區及歐洲對沖基金表現大獎

EQS 新聞 via SEAPRWire.com / 2024-09-24 / 09:00 UTC+8 2024年9月16日,ActusRayPartners (“ARP”) 榮獲 With Intelligence 頒發「2024年 HFM 亞太區對沖基金表現大獎 (HFM APAC Performance Awards 2024)」的「年度新晉基金 (New Fund of the Year)」獎項。此獎項旨在表彰ARP亞洲阿爾法基金(ActusRayPartners Asia Alpha Fund)於2023年4月1日至2024年3月31日期間的傑出表現,標誌著該基金在成立首年的成功。 此外,ARP亦於2023年10月12日榮獲「2023年 HFM 歐洲對沖基金表現大獎」的「新晉股權基金 (Equity Newcomer)」獎項。該獎項肯定了ARP歐洲阿爾法基金 (ActusRayPartners European Alpha Fund) 於2022年7月1日至2023年6月30日期間的卓越表現。自2021年3月推出以來,該基金每年都持續獲得對沖基金表現大獎的提名。 ARP 是一家以量化為導向但最終以自主決策為主的對沖基金管理公司,由新鴻基有限公司(「新鴻基公司」,香港聯交所:86)旗下的基金管理平台Sun Hung Kai Capital Partners種子投資和支持。自2019 年成立以來,ARP的業績取得顯著增長。其資產管理規模 (AUM) 自成立以來增長了超過35倍,截至 2024 年 8 月 31 日,達到約 7.7 億美元。 ARP 的三位共同創始人表示:「我們的歐洲和亞洲基金雙雙榮獲表現大獎,展現了我們團隊在不同地域有效應用我們的『自主概率投資』流程的能力。」 新鴻基公司副行政總裁 Tony Edwards 表示祝賀:「恭喜 ARP 團隊贏得兩項 HFM 表現大獎!新鴻基公司致力於支持和培育亞洲地區優秀且具專業能力的新晉資產管理公司,賦能他們實現卓越表現,ARP 就是我們伙伴合作關係的一個典型成功例子。即使在市場波動中仍然能夠展現其韌性和強勁的業績。我們期待未來與 ARP 一起實現更多里程碑。」 HFM 對沖基金表現大獎在對沖基金業界備受推崇,旨在表彰基金表現、營運能力及服務供應商等不同範疇的突出成就。該獎項由頭部對沖基金市場資訊公司HFM Global 舉辦,擁有悠久歷史,歷年來致力表彰表現超卓、具有創新能力的公司。 – 完 – ActusRayPartners共同創辦人張泓、安力德、及陳兆偉(左至右) ActusRayPartners 執行委員會、ActusRayPartners Business Manager王楚詠,以及新鴻基有限公司的代表 關於ActusRayPartners ActusRayPartners是一家總部位於香港的資產管理公司,由安力德 (Andrew Alexander)、陳兆偉(Raymond Chan)和張泓(Patrick Cheung) 於2019年共同平等創立。團隊成員曾於麥格理量化對冲基金擔任前線人員。目前, ActusRayPartners 在香港及悉尼共擁有26名成員,截至2024年8月31日,負責管理歐洲及亞洲接近7.7億美元的資金。 ActusRayPartners採用的「自主概率投資」流程綜合了:1)量化基礎;以及2)自主調整去應對量化投資的盲點。量化基礎使用了基本面、分析員預測、技術及另類數據,並採用高級統計、自然語言處理及人工智能模型。投資經理的自主調整工作專注於應對純粹量化投資的挑戰,而非單純基本面、宏觀或資金流動分析。 關於新鴻基有限公司 及 Sun Hung Kai Capital Partners 新鴻基有限公司 (香港股份代號:86) (「新鴻基公司」/「本公司」,連同其附屬公司「本集團」) 是一家領先的香港金融機構,在另類投資和財富管理領域備受肯定。新鴻基公司成立於1969年,其多元化的投資組合,涵蓋公開市場、信貸和另類投資策略(其中包括房地產和私募股權),締造長期經風險調整回報。 憑藉其紮根亞洲的傳承,新鴻基公司支持和培育該地區優秀且具專業能力的新晉資產管理公司,賦能他們實現卓越表現。集團亦利用其長久以來建立的投資業務專長和豐富資源,透過其家族辦公室解決方案,為理念一致的合作伙伴和超高淨值投資者提供量身定制的投資解決方案。截至2024年6月30日,集團的資產總值約為395億港元。 有關新鴻基有限公司更多的資訊,請瀏覽 www.shkco.com 或關注公司領英。 Sun Hung Kai Capital Partners成立於2020年,是新鴻基有限公司旗下受香港證監會監管的子公司,持有第一、四及九類牌照。有關詳情,請瀏覽 www.shkcapital.com 或於領英關注Sun Hung Kai Capital Partners。 媒體查詢,請聯絡: Hill and Knowlton 林貴珍 +852 9839 6552 張夢瑩 +852 9794 5751 電郵:SHKCo@hkstrategies.com 2024-09-24 此財經新聞稿由EQS Group via SEAPRWire.com轉載。本公告內容由發行人全權負責。瀏覽原文: http://www.todayir.com/tc/index.php
More
Ensign InfoSecurity Recognised as Honouree in NextGen Tech 30, ASEAN’s First Public-Private Initiative to Recognise Growth Companies of the Region ACN Newswire

Ensign InfoSecurity Recognised as Honouree in NextGen Tech 30, ASEAN’s First Public-Private Initiative to Recognise Growth Companies of the Region

SINGAPORE, Sept 24, 2024 - (ACN Newswire via SeaPRwire.com) - Ensign InfoSecurity (“Ensign”), one of Asia’s largest comprehensive cybersecurity service providers, has been named an honouree in the prestigious NextGen Tech 30, the region’s first initiative spotlighting home-grown growth stage companies transforming the ASEAN economy. Organised by Granite Asia in partnership with key players such as 65 Equity Partners, DBS Bank, EDBI, Infocomm Media Development Authority, KKR, Northstar Group, Singapore Business Federation and Singapore Exchange, NextGen Tech 30 identifies companies driving exceptional innovation and growth across Automation, Enterprise Solutions, and Food Tech & Brands.Ensign’s recognition in the Enterprise Solutions category of the NextGen Tech 30 marks a significant milestone in its growth across ASEAN. This accolade reinforces the company’s leadership in cybersecurity innovation and its role in strengthening digital resilience across the region. Powered by its in-house research and development, Ensign delivers proprietary solutions designed to address the growing complexity of cyber threats. These technologies, underpinned by patented methodologies, provide cutting-edge protection for both public and private sector organisations.Since its inception in 2018, Ensign has evolved into a world-class cybersecurity company with an Asia-first approach. Acting as a single point of accountability, Ensign provides a comprehensive, threat-informed suite of services spanning advisory, assurance, architecture design, systems integration, managed security, and incident response. Leveraging AI, data science, and deep threat analysis, the company delivers tailored solutions to address the specific cybersecurity challenges faced by its clients.A key highlight of Ensign’s recent innovations is the launch of Aletheia, a cutting-edge deepfake detection solution designed to safeguard enterprises, governments and consumers from the growing threat of AI-manipulated media. Aletheia represents a significant advancement in cybersecurity, leveraging AI to detect deepfakes in real time, within seconds and achieving up to 90% accuracy."We are honoured to be named a NextGen Tech 30 honouree. This recognition underscores our dedication to pushing the boundaries of cybersecurity innovation while supporting the digital growth of the ASEAN economy. At Ensign, we are focused on developing AI-driven solutions that not only address today’s threats but also equip organisations to stay ahead of future challenges,” said Tammie Tham, Group Chief Executive Officer of Ensign InfoSecurity.The NextGen Tech 30 is backed by a panel of esteemed industry leaders and investors including Mukul Chawla, Head of Asia Pacific Growth Equity at KKR; Kok Ping Soon, CEO of Singapore Business Federation; Jenny Lee, Senior Managing Partner of Granite Asia; Lew Chuen Hong, Chief Executive of Infocomm Media Development Authority; Paul Ng, CEO of EDBI; Ng Yao Loong, CFO of SGX Group; Tan Su Shan, Group Head of Institutional Banking at DBS Bank; Adrienne Teh, Managing Director of 65 Equity Partners; Wong Chee-Yann, Group CIO at Northstar Group, further cementing the significance of this accolade.About Ensign InfoSecurityEnsign InfoSecurity is the largest comprehensive cybersecurity service provider in Asia. Headquartered in Singapore, Ensign offers bespoke solutions and services to address their clients’ cybersecurity needs. Their core competencies are in the provision of cybersecurity advisory and assurance services, architecture design and systems integration services, and managed security services for advanced threat detection, threat hunting, and incident response. Underpinning these competencies is in-house research and development in cybersecurity. Ensign has two decades of proven track record as a trusted and relevant service provider, serving clients from the public and private sectors in the Asia Pacific region.For more information, visit www.ensigninfosecurity.com or email media@ensigninfosecurity.com. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
英國首相基爾·斯塔默因接受免費贈品而陷入困境,堅稱自己沒有做錯任何事 News

英國首相基爾·斯塔默因接受免費贈品而陷入困境,堅稱自己沒有做錯任何事

(SeaPRwire) - 尽管上任还不到三个月,基尔·斯塔默就已经因接受来自一位富商的服装和其他礼物形式的捐赠而引起了人们的关注。 这位在承诺恢复政治信任的承诺下以压倒性胜利赢得大选的领导人,否认了有关由媒体企业家兼长期党派捐助者 Waheed Alli 支付的价值数千英镑的服装和眼镜有任何不当行为。 斯塔默的麻烦加剧了,因为一份披露显示他的幕僚长苏·格雷的年薪为 170,000 英镑,即 225,000 美元,比首相的年薪高出约 3,000 英镑。作为前高级公务员,格雷最出名的是领导了对政府大楼在新冠肺炎期间违反封锁措施举行派对的调查。格雷的调查结果导致保守党首相鲍里斯·约翰逊下台,她随后转投斯塔默麾下,导致保守党声称“派对门”调查存在政治偏见——格雷否认了这一说法。与此同时,工党指责保守党在制造争议以玷污政府。 议员可以接受礼物,但必须在 28 天内申报捐赠和议会之外的收入——斯塔默错过了这一期限。他将延误归咎于他的工作人员正在寻求有关究竟需要申报什么的建议。斯塔默本周表示:“我对遵守规则非常一致”,他拒绝了关于首相应该获得衣物预算的建议。斯塔默驳斥了有关其工作人员对格雷及其薪酬存在异议的说法,坚称他“完全掌控局面”。他周四告诉英国广播公司:“我专注于工作,每天我给团队传达的信息都是一样的,那就是我们必须有所作为。”“我们是在一个巨大的变革授权下当选的,我决心要做到这一点。”斯塔默及其妻子维多利亚接受的免费物品规模让即使是他的支持者也感到困惑。天空新闻报道称,斯塔默自 2019 年 12 月以来申报的“礼物、福利和招待”价值超过 100,000 英镑,超过任何其他议员。这些捐款包括数千英镑的英超联赛门票,这些门票涉及首相最喜欢的足球队阿森纳。在争议爆发后,工党表示斯塔默不会再接受任何免费服装。 副首相安吉拉·雷纳也接受了用于支付服装的捐款,她告诉英国广播公司:“我理解人们的愤怒,[但是]礼物和招待以及金钱捐赠的捐赠一直是我们政治中的一项重要特征。”雷纳说:“人们可以查看这些信息,看看人们获得了哪些捐赠,透明度非常重要。 工党领导人希望从周日开始的为期四天的年度会议能够为该党注入一些急需的士气。 Digital 已联系 10 唐宁街和 Alli 寻求进一步评论。 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Creative Group 入選 MeetingsNet 2024 CMI 25 名單 Business

Creative Group 入選 MeetingsNet 2024 CMI 25 名單

(SeaPRwire) - 這是 MeetingsNet 第 18 年表彰 北美 最大和最具影響力的會議和獎勵旅遊公司,Creative Group 再次榜上有名。 伊利諾伊州沙姆堡,2024 年 9 月 23 日 — Creative Group 今天宣布,連續第 18 年入選 MeetingsNet 的 2024 年 CMI 25 名單,表彰專注於美國企業市場的規模最大、影響力最廣的全方位會議和獎勵旅遊管理公司。 MeetingsNet 是一家媒體品牌,提供會議和會展行業的新聞和分析,其年度報告是尋找經驗豐富的商業活動規劃合作夥伴的公司的首選資源。作為一個整體,2024 年 CMI 25 名單上的組織在 2023 年執行了近 150,000 場企業會議和超過 1,400 個獎勵旅遊計劃,總共這些活動在世界各地的酒店和度假村使用了超過 700 萬個房間晚數。 該名單包括業務量和主要客戶市場的統計數據,以及公司內部新聞,讓讀者了解每家公司的重點、優勢和規模。 “向那些入選 CMI 25 的公司致敬,他們是讓群體聚在一起進行培訓和教育、表彰、聯繫、品牌建設等活動的重要合作夥伴。成功的會議管理需要創意、經驗和對細節的關注的特殊組合,而 CMI 25 的公司已在一次又一次的活動中證明了自己的實力,”MeetingsNet 內容總監 Sue Hatch 說道。 “我們很自豪能連續第 18 年入選 CMI 25 名單,”Creative Group 總裁 Janet Traphagen 說。“隨著會議和獎勵在促進連接性、管理變革以及在日益脫節的世界中建立信任方面越來越具有戰略意義,我們很榮幸能因在創造難忘且可衡量的體驗方面的領導地位而獲得表彰,這些體驗旨在幫助我們的客戶及其員工蓬勃發展。” MeetingsNet 編輯根據多個因素選出了 2024 年 CMI 25 家公司,包括 2023 年管理的會議和獎勵旅遊計劃的數量,以及這些會議和獎勵活動所代表的房間晚數的總數。他們還考慮了每家公司的全職員工數量,以及公司 2023 年收入中來自組織企業會議和獎勵活動的百分比,與協會會議或其他來源相比。 關於 Creative Group Creative Group 是一家 Direct Travel 公司,是一家提供全方位會議、活動、獎勵和表彰服務的機構,專注於端到端的會議和獎勵活動規劃、執行和測量。作為行業領導者,Creative Group 獲得了多個獎項,包括 SITE 水晶獎和 CMI 25 獎,該獎項表彰美國 25 家最具影響力的會議和獎勵管理公司。 Creative Group 成立於 1970 年,為科技、金融服務、生命科學、保險、製造業、零售業、汽車業、酒店業等行業的客戶提供服務。該公司在 伊利諾伊州沙姆堡 設有總部,員工超過 200 人,在 加州舊金山、威斯康辛州阿普爾頓 和 加拿大多倫多 附近設有辦事處。有關 Creative Group 的更多信息,請訪問 . SOURCE Creative Group, Inc.本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
美國增兵中東,內塔尼亞胡警告黎巴嫩人民,以黎衝突升級 News

美國增兵中東,內塔尼亞胡警告黎巴嫩人民,以黎衝突升級

(SeaPRwire) - 美國正在向中東派遣更多部隊,以色列總理內塔尼亞胡對黎巴嫩人民發出警告,警告他們注意與真主黨之間升級的衝突。「鑑於緊張局勢加劇,出於謹慎,我們將派遣少數額外的美國軍隊前往增援我們已在該地區的部隊。但出於行動安全的考慮,我不會評論或提供具體細節,」美國陸軍少將帕特·雷德在週一非公開的簡報會上對記者說。美國目前在該地區已有 40,000 名軍隊。新的部署是在以色列部隊對黎巴嫩境內目標發動重大襲擊之後發生的,這些襲擊造成數百人喪生,同時以色列正在準備進行進一步的行動。內塔尼亞胡週一發布了一段視頻聲明,對「黎巴嫩人民」發言。「以色列的戰爭不是對你的。而是對真主黨。太久了,真主黨一直在利用你們當人肉盾牌。他們把火箭放在你們的客廳裡,把導彈放在你們的車庫裡,」內塔尼亞胡說。「這些火箭和導彈是直接針對我們的城市,直接針對我們的公民。為了保護我們的人民免受真主黨的襲擊,我們必須摧毀這些武器。」「現在,從今天早上開始,以色列國防軍已經警告你們離開危險地帶,」內塔尼亞胡補充說。「我敦促你們——認真對待這個警告。不要讓真主黨危及你們的生命和你們親人的生命。不要讓真主黨……。請現在離開危險地帶。一旦我們的行動結束,你們就可以安全地回到家中。」他說話時,以色列戰機繼續襲擊黎巴嫩南部和東部的真主黨目標。以色列政府確認,內塔尼亞胡的內閣週一批准了以色列內部的「特殊情況」——類似於緊急狀態。根據以色列政府的說法,該宣言顯著擴大了以色列國防軍(IDF)的權力,使其能夠發布公開指令,允許軍方禁止集會、限制學習並發布「為拯救生命而必需的額外指令」。美國國務院正在警告美國人離開黎巴嫩,因為爆發地區戰爭的風險正在增加。「由於真主黨和以色列之間持續衝突的不可預測性以及黎巴嫩各地最近發生的爆炸,包括貝魯特,美國大使館敦促美國公民在商業選擇仍然可行的情況下離開黎巴嫩,」國務院週六警告說。雷德沒有說明如果需要,額外的部隊是否會支持這些公民的撤離。此外,週一,美國海軍的航空母艦,兩艘驅逐艦和一艘巡洋艦從弗吉尼亞州諾福克出發,前往地中海進行定期的部署,這為美國有可能讓杜魯門號和位於阿曼灣的美國海軍航空母艦亞伯拉罕·林肯號保持在附近打開了可能性,以防爆發進一步的暴力,據美聯社報導。 雷德說,國防部長勞埃德·奧斯汀週末與以色列國防部長約阿夫·加蘭特進行了背靠背的電話會談,他在電話中敦促停火並緩和該地區的緊張局勢。「鑑於緊張局勢,鑑於局勢升級,正如我所強調的,存在爆發更廣泛地區衝突的可能性。我不認為我們已經到了那一步,但這是一個危險的局勢,」雷德說。美國在中東的存在旨在幫助保衛以色列,並保護美國和盟國的人員和資產。美國海軍軍艦遍布整個地區,從地中海東部到阿曼灣,空軍和海軍戰鬥機都戰略性地部署在幾個地點,以便更好地應對任何攻擊。' Yonat Friling 和 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
五糧液全球和諧之旅:「香遇」義大利 Business

五糧液全球和諧之旅:「香遇」義大利

(SeaPRwire) - 米蘭,2024 年 9 月 23 日 — 在2024 年 9 月 16 日,以「香遇世界:和諧共生」為主題,五糧液「全球和諧之旅」重返歐洲,開啟意大利的新旅程,以美酒為紐帶。看似跨學科的文化交流,實則為五糧液精心策劃的文化盛宴。目標是通過美酒的通用語言,促進頂尖水平的文化對話,通過深入的交流和學習,為五糧液的高質量發展帶來新的靈感和動力。 2023 年,五糧液與Campari 集團合作,以五糧液 40% 酒精濃度的香型基酒「五谷頌」替代琴酒,創造出「Wugroni」雞尾酒。這標誌著中西融合的新模式,將中國白酒國際化,並將雞尾酒文化本土化於中國。2024 年,合作加深,Wugroni 雞尾酒在中國、美國、意大利、法國、德國、英國和新加坡等 700 多家酒吧推出,邁向國際消費者市場。 同時,五糧液與意大利頂級奢侈品牌 Bulgari 合作,探索跨類別的交流與合作。五糧液正在探索未來其產品在 Bulgari 酒店、餐廳和酒吧中亮相的可能性。 在參觀歐洲設計學院 (IED) 時,五糧液表示:「這次與 IED 深入的參觀和交流,讓我們在產品設計、酒類創新和工藝等領域學習和合作。通過借鑒全球頂尖工業設計理念和經驗,我們旨在將高質量發展成果轉化為更高品質的生活。」 此外,當地時間9 月 17 日,「和諧之夜」海外華人慶祝中華人民共和國成立 75 周年和中秋節活動在意大利米蘭舉行。五糧液作為活動的「尊貴合作夥伴」和「指定酒品」隆重亮相,與海外華人共慶佳節,推廣中華文化。五糧液集團股份有限公司董事長曾從欽通過視頻發表講話,表示:「和諧是中華文化的精髓,也是海外華人孜孜不倦的追求。無論身在何處,和諧、共處、團聚都是中國人民永恒的願望。 聯繫:Joy Li, 標誌 – 照片 – 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
亞洲股市在市場波動中保持穩定 Business

亞洲股市在市場波動中保持穩定

(SeaPRwire) - 儘管全球經濟持續存在不確定性,亞洲股市表現出顯著的韌性。該地區的投資者正在密切關注各種經濟指標和企業收益,以評估市場走向。 在值得注意的股票中,日本的日經指數成功保持穩定,反映了投資者對日本經濟政策和企業表現的信心。日經指數包含索尼和豐田等主要公司,一直是亞洲市場情緒的风向标。 在中國,上海綜合指數也表現出穩定,儘管對中國經濟放緩的擔憂仍然存在。中國政府實施了支持經濟增長的措施,這些措施已得到市場的廣泛歡迎。 韓國的 KOSPI 指數表現喜憂參半,三星電子 (KRX:005930) 等科技股推動了漲幅,而其他行業則落後。科技行業的強勁表現證明了全球對半導體和先進電子產品的需求。 澳大利亞的 ASX 200 指數出現輕微波動,受商品價格變化的影響。必和必拓和力拓等礦業和能源領域的公司受到這些價格波動的特別影響。 總體而言,亞洲股市正在應對複雜的局勢,投資者在對經濟復甦持樂觀態度的同時,也對潛在風險保持謹慎。未來幾週對於判斷這種穩定性是否能夠維持至關重要。 隨著全球市場繼續對經濟數據和地緣政治發展做出反應,亞洲投資者需要保持警惕,適應不斷變化的環境。日經指數、上證綜指、KOSPI 和 ASX 200 等主要指數的表現將為該地區的經濟健康和投資者情緒提供寶貴的見解。 Footnotes:本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 亞洲股市表現出韌性,儘管全球存在不確定性。 .
More
Ibotta 的執行長談創業挑戰 Business

Ibotta 的執行長談創業挑戰

(SeaPRwire) - 正如 Ibotta 的執行長所解釋,新創公司在擴展營運規模時經常面臨一組獨特的挑戰。其中一個主要問題是在成長和維持永續商業模式之間取得平衡。這對於科技領域的公司尤其重要,因為快速創新和競爭是常態。 現金回饋獎勵應用程式 Ibotta 的執行長布萊恩·李奇表示,新創公司需要在追求指數型成長之前,先專注於建立堅實的基礎。李奇強調了解市場需求以及確保產品能與消費者需求良好結合的重要性。他解釋:「我們必須多次轉型,才能找到適合的產品市場契合點。」 另一個對新創公司來說重要的挑戰是資金取得。儘管有大量的風險資本,但並非所有新創公司都能吸引到合適的投資。李奇指出,擁有清晰的營收模式和獲利途徑對於說服投資者至關重要。他說:「投資者尋找的是永續成長,而不仅仅是炫麗的數字。」 員工留任是另一個障礙。新創公司通常以成長和創新的承諾吸引人才,但在公司面臨不可避免的坎坷時,留住這些人才可能很困難。李奇建議,維持透明和包容的公司文化有助於留住員工。他補充說:「我們確保每個人都了解公司的願景以及他們在其中的角色。」 此外,監管挑戰也會造成重大障礙。某些產業的新創公司,例如金融科技和醫療保健,可能會發現自己在複雜的監管環境中摸索。李奇指出,在創新的同時保持合規是一件很棘手的事。他提到:「我們不得不大量投資於合規部門,以確保我們符合所有監管要求。」 儘管面臨這些挑戰,李奇仍然對新創公司的未來持樂觀態度。他認為,克服這些障礙的關鍵在於韌性和適應性。他總結道:「能夠轉型並適應環境變化的新創公司將會成功。」 註腳:本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 布萊恩·李奇討論了找到適當產品市場契合點的重要性。 . 李奇強調投資者尋找的是永續成長。 .
More
FedEx 財報不如預期:潛在經濟訊號 Business

FedEx 財報不如預期:潛在經濟訊號

(SeaPRwire) - FedEx (NYSE:FDX) 最近公布的盈利未達分析師預期,引發人們對整體經濟潛在信號的擔憂。該公司的收入和利潤數字受到密切關注,因為 FedEx 經常被視為經濟活動的晴雨表,這得益於其全球航運和物流業務。 在最近一個季度,FedEx 的每股收益為 3.44 美元,低於預期的 3.68 美元。收入也未達預期,為 228 億美元,而預期為 235 億美元。這些結果導致 FedEx 股價下跌,在公告後下跌了約 4%。 該公司的首席執行官強調了導致盈利不及預期的幾個因素,包括更高的營運成本和歐洲和亞洲的需求疲軟。首席執行官還指出,持續的供應鏈中斷和勞動力短缺給公司帶來了重大挑戰。 FedEx 的業績通常被視為全球經濟的晴雨表,因為它處理的包裹量可以反映更廣泛的經濟活動。航運量放緩可能表明消費者支出和商業活動減少,這可能對經濟增長產生更廣泛的影響。分析師目前正在爭論 FedEx 的盈利不及預期是否是潛在經濟放緩的跡象,還是更多地表明公司特定問題。 為應對盈利報告,FedEx 宣布了旨在提高營運效率和成本管理的幾項戰略舉措。這包括投資自動化和技術,以簡化營運並降低勞動力成本。該公司還計劃優化其網路並增強其電子商務功能,以更好地為不斷增長的線上購物市場服務。 投資者和市場觀察人士將密切關注 FedEx 在未來幾個季度的表現,以評估該公司能否克服當前挑戰並重回增長。FedEx 盈利不及預期的更廣泛的市場影響也將成為重點關注領域,因為它可能會提供有關全球經濟健康狀況的洞察。 Footnotes: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 FedEx 的盈利不及預期,原因是營運成本上升以及歐洲和亞洲的需求疲軟。 . 該公司計劃優化其網路並增強電子商務功能。 .
More
馬克思主義領袖宣誓就任擁有2200萬人口國家的總統 News

馬克思主義領袖宣誓就任擁有2200萬人口國家的總統

(SeaPRwire) - 斯里蘭卡總統阿努拉·庫馬拉·迪薩納亞克(Anura Kumara Dissanayake)週一正式就職。55 歲的迪薩納亞克,他的政黨被指責導致國家陷入經濟危機。新領袖的政黨是人民解放陣線(People's Liberation Front),一個馬克思主義團體,在 1970 年代和 1980 年代發動了兩次武裝起義。「我們深知,我們將面臨一個充滿挑戰的國家,」迪薩納亞克在就職典禮上說。「我們不相信任何政府、任何單一政黨或任何個人能夠解決這種深重的危機。中國於週一對迪薩納亞克表示祝賀,表示中國期待與斯里蘭卡共同「推進我們傳統的友誼」。美國和印度此前也對迪薩納亞克表示祝賀。這個擁有 2200 萬人口的國家(約等於西維吉尼亞州的人口)位於印度南部,許多選民表示,他們對該國的政治文化感到不滿,因為該國正慢慢擺脫經濟危機。路透社報導,2022 年因嚴重美元短缺導致通貨膨脹率飆升至 70%。然而,通貨膨脹率已有所下降,該國 GDP 預計將「三年來首次」出現增長。迪薩納亞克的就職典禮是自 2022 年以來斯里蘭卡首次標準的權力交接,當時暴動迫使時任總統戈塔巴雅·拉賈帕克薩(Gotabaya Rajapaksa)辭職並逃離該國。隨後,維克勒馬辛哈(Wickremesinghe)取代了他的職位。迪薩納亞克的首要任務將是兌現其競選承諾,放鬆前任總統維克勒馬辛哈在與國際貨幣基金組織(IMF,該國最大的債權人)的救助協議下實施的緊縮措施。美聯社和路透社對本報告有貢獻本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More